The importance of personalized medicine in urological cancers
Khatami F, Hassanzad M, Nikfar S, Guitynavard F, Karimaee S, Tamehri Zadeh S, Gholami K, Rezaeian A, Feiz-Abadi S, Jahanshahi F, Aghamir S. The importance of personalized medicine in urological cancers. Journal Of Diabetes & Metabolic Disorders 2021, 21: 841-852. PMID: 35673449, PMCID: PMC9167380, DOI: 10.1007/s40200-021-00824-0.Peer-Reviewed Original ResearchAndrogen deprivation therapyExcision repair cross-complementing group 1Prostate cancerAndrogen receptorUrological cancersResistance to androgen deprivation therapyPersonalized medicineAssociated with metastatic potentialAdvanced prostate cancerMetastatic bladder cancerPersonalized therapeutic regimensDNA-damaging chemotherapyDeprivation therapyAndrogen independenceMuscle-invasiveTargeted therapyTherapeutic regimensBladder cancerPoor prognosisMetastatic potentialTumor developmentGroup 1PTEN geneMolecular profilingCancer